Oxford

Oxford-based Ultromics, which has developed the first FDA-cleared, Medicare-reimbursed AI tools for cardiology diagnostics, raised a $55M Series C

The funding will accelerate Ultromics' mission to advance heart disease detection and scale EchoGo®, its AI platform for earlier, more accurate diagnoses.

Oxford-based Exscientia, which uses AI to help discover new pharmaceuticals, raises up to $525M in Series D funding led by SoftBank

London-based startup Blue Vision Labs, which helps developers build collaborative AR apps, raises $14.5M Series A led by GV

Blue Vision Labs, a London-based augmented reality startup co-founded by computer vision experts from Oxford and Imperial College, is emerging from stealth today …